Liz Hookham

Liz Hookham currently serves as the Principal Analyst in the Opportunity Assessment Group at LifeArc, where responsibilities include leading business partnering efforts for Translational Challenges in Chronic Respiratory Infection, Rare Diseases, and Childhood Cancer. In previous roles at LifeArc, Liz led matrix teams for competitive intelligence activities and conducted due diligence on drug development opportunities. Prior to LifeArc, Liz was a Postdoctoral Research Associate at University College London, focusing on neurosteroids and GABA(A) receptors in neuropathic pain under the MRC Centenary Award. Liz holds a PhD in Cell and Molecular Biology from UCL and a Master's degree in Biochemistry from the University of Oxford.